Alemtuzumab for the treatment of multiple sclerosis

por Willis, Mark D, Robertson, Neil P
Publicado 2015

Alemtuzumab for Multiple Sclerosis

por Willis, Mark D., Robertson, Neil P.
Publicado 2016

Targeted suppression of autoreactive CD8(+) T-cell activation using blocking anti-CD8 antibodies

por Clement, Mathew, Pearson, James A., Gras, Stephanie, van den Berg, Hugo A., Lissina, Anya, Llewellyn-Lacey, Sian, Willis, Mark D., Dockree, Tamsin, McLaren, James E., Ekeruche-Makinde, Julia, Gostick, Emma, Robertson, Neil P., Rossjohn, Jamie, Burrows, Scott R., Price, David A., Wong, F. Susan, Peakman, Mark, Skowera, Ania, Wooldridge, Linda
Publicado 2016